Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Hepatitis C virus modulates lipid regulatory factor Angiopoietin-like 3 gene expression by repressing HNF-1α activity.

Foka P, Karamichali E, Dalagiorgou G, Serti E, Doumba PP, Pissas G, Kakkanas A, Kazazi D, Kochlios E, Gaitanou M, Koskinas J, Georgopoulou U, Mavromara P.

J Hepatol. 2014 Jan;60(1):30-8. doi: 10.1016/j.jhep.2013.08.016. Epub 2013 Aug 23.

PMID:
23978712
2.

Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1α.

Matsui C, Shoji I, Kaneda S, Sianipar IR, Deng L, Hotta H.

J Virol. 2012 Dec;86(23):12903-11. doi: 10.1128/JVI.01418-12. Epub 2012 Sep 19.

3.

Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor.

Inaba T, Matsuda M, Shimamura M, Takei N, Terasaka N, Ando Y, Yasumo H, Koishi R, Makishima M, Shimomura I.

J Biol Chem. 2003 Jun 13;278(24):21344-51. Epub 2003 Apr 1.

4.

Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.

Yoshikawa T, Ide T, Shimano H, Yahagi N, Amemiya-Kudo M, Matsuzaka T, Yatoh S, Kitamine T, Okazaki H, Tamura Y, Sekiya M, Takahashi A, Hasty AH, Sato R, Sone H, Osuga J, Ishibashi S, Yamada N.

Mol Endocrinol. 2003 Jul;17(7):1240-54. Epub 2003 May 1.

PMID:
12730331
5.

Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication.

García-Mediavilla MV, Pisonero-Vaquero S, Lima-Cabello E, Benedicto I, Majano PL, Jorquera F, González-Gallego J, Sánchez-Campos S.

Lab Invest. 2012 Aug;92(8):1191-202. doi: 10.1038/labinvest.2012.88. Epub 2012 May 28.

6.

Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.

Matsui C, Deng L, Minami N, Abe T, Koike K, Shoji I.

J Virol. 2018 Jun 13;92(13). pii: e00639-18. doi: 10.1128/JVI.00639-18. Print 2018 Jul 1.

PMID:
29695419
9.

Transcription of the human microsomal epoxide hydrolase gene (EPHX1) is regulated by an HNF-4α/CAR/RXR/PSF complex.

Peng H, Zhu QS, Zhong S, Levy D.

Biochim Biophys Acta. 2013 Oct;1829(10):1000-9. doi: 10.1016/j.bbagrm.2013.05.003. Epub 2013 May 26.

PMID:
23714182
10.

Hepatocyte nuclear factor (HNF) 1 and HNF4 mediate hepatic multidrug resistance protein 2 up-regulation during hepatitis C virus gene expression.

Qadri I, Iwahashi M, Kullak-Ublick GA, Simon FR.

Mol Pharmacol. 2006 Aug;70(2):627-36. Epub 2006 May 2.

11.

Arylacetamide deacetylase: a novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production.

Nourbakhsh M, Douglas DN, Pu CH, Lewis JT, Kawahara T, Lisboa LF, Wei E, Asthana S, Quiroga AD, Law LM, Chen C, Addison WR, Nelson R, Houghton M, Lehner R, Kneteman NM.

J Hepatol. 2013 Aug;59(2):336-43. doi: 10.1016/j.jhep.2013.03.022. Epub 2013 Mar 28.

PMID:
23542347
16.

Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis.

Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y, Abe T, Murata S, Tanaka K, Miyamura T, Suzuki T, Koike K, Matsuura Y.

Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1661-6. Epub 2007 Jan 18.

17.

Ligand-activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR.

Matsusue K, Miyoshi A, Yamano S, Gonzalez FJ.

Mol Cell Endocrinol. 2006 Aug 15;256(1-2):23-33.

18.

Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.

Farquhar MJ, Humphreys IS, Rudge SA, Wilson GK, Bhattacharya B, Ciaccia M, Hu K, Zhang Q, Mailly L, Reynolds GM, Ashcroft M, Balfe P, Baumert TF, Roessler S, Wakelam MJO, McKeating JA.

J Hepatol. 2017 May;66(5):919-929. doi: 10.1016/j.jhep.2017.01.009. Epub 2017 Jan 23.

PMID:
28126468
19.

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.

Sun HY, Lin CC, Lee JC, Wang SW, Cheng PN, Wu IC, Chang TT, Lai MD, Shieh DB, Young KC.

Gut. 2013 Aug;62(8):1193-203. doi: 10.1136/gutjnl-2011-301798. Epub 2012 Jun 11.

PMID:
22689516
20.

Supplemental Content

Support Center